<DOC>
	<DOCNO>NCT02501486</DOCNO>
	<brief_summary>Rationale : Case report describe suppression hypothalamic-pituitary-adrenal ( HPA ) axis cause local corticosteroid , often inhalation corticosteroid . The exact prevalence know . Early recognition important , suppression HPA-axis lead significant morbidity mortality . Suppression HPA axis might occur often Cytochrome P450 3A4 ( CYP3A4 ) inhibitor , e.g . ritonavir , use next local corticosteroid , combination often use human immunodeficiency virus ( HIV ) -patients . Cortisol determine hair . This non-invasive analysis could help diagnosis suppressed HPA-axis . Research question : Primary objective : 1 . How often inhalation nasal corticosteroid lead suppression HPA- axis HIV-treated patient ? Secondary objective : 2 . Are variable associate HPA-axis suppression ? 3 . Are cortisol measurement hair reliable serum cortisol Adrenocorticotropic hormone ( ACTH ) stimulation test diagnose suppression HPA axis ? Study design : cross-sectional explorative study Study population : adult treat HIV use inhalation nasal corticosteroid . Intervention : ACTH stimulation test , cortisol measurement blood hair . Main study parameters/endpoints : Proportions person low morning plasma cortisol low cortisol ACTH stimulation test . Correlation cortisol plasma hair cortisol . Nature extent burden risk associate participation , benefit group relatedness : Each person screen history short physical examination . A venous cannula insert obtain blood plasma cortisol ACTH stimulation test . An ACTH stimulation test major complication . A piece hair cut cortisol hair analysis . The risk burden minimal , future benefit could great since suppression endogenous HPA- axis associate morbidity like hypertension osteoporosis even lead adrenal crisis local corticosteroid stop .</brief_summary>
	<brief_title>Inhalation/Nasal Corticosteroids Prevalence Hypothalamic-pituitary-adrenal ( HPA ) Axis Suppression Human Immunodeficiency Virus ( HIV ) -Patients</brief_title>
	<detailed_description />
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Receive treatment HIVinfection &gt; 18 year old Current usage inhalation nasal corticosteroid , least two week Willing give inform consent adrenal insufficiency Concurrent use topical corticosteroid , usage oral corticosteroid last three month . Intramuscular intraarticular corticosteroid injection last year . Contraindications tetracosactide : allergy tetracosactide , Cushings 's syndrome , refractory heart failure , peptic ulcer , acute psychosis , adrenogenital syndrome If patient ever ACTHstimulation test Pregnant female breastfeed female . Use oral contraceptive , since heighten cortisolbinding globulin Exclusion criterion cortisol measurement hair : baldness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>adrenal insufficiency</keyword>
	<keyword>adverse drug reaction</keyword>
	<keyword>corticosteroid</keyword>
</DOC>